Results 21 to 30 of about 192,978 (193)

Lipid accumulation product and visceral adiposity index: two indices to predict metabolic syndrome and insulin resistance in chronic kidney disease patients

open access: yesEndocrine Regulations, 2023
Objective. Chronic kidney disease (CKD), metabolic syndrome (MetS) and insulin resistance (IR) are the major health problems associated with the increasing risk of cardiovascular and cerebrovascular complications.
Fahmy Ahmed Mohamed   +4 more
doaj   +1 more source

Cardiovascular-kidney-metabolic syndrome: Risk factors and management considerations

open access: yesAsian Journal of Surgery
Yumei Chen   +3 more
doaj   +2 more sources

Metabolic Syndrome and Outcomes after Renal Intervention

open access: yesCardiology Research and Practice, 2011
Metabolic syndrome significantly increases the risk for cardiovascular disease and chronic kidney disease. The increased risk for cardiovascular diseases can partly be caused by a prothrombotic state that exists because of abdominal obesity.
Daynene Vykoukal, Mark G. Davies
doaj   +1 more source

Social Determinants of Health and Mortality in Cardiovascular-Kidney-Metabolic Syndrome. [PDF]

open access: yesJACC Adv
Chang R   +9 more
europepmc   +4 more sources

La sindrome cardio-nefro-metabolica

open access: yesItalian Journal of Medicine
Introduzione M. Meschi, D. Manfellotto, A. Montagnani Aspetti clinici e diagnostici della cardiovascular-kidney-metabolic syndrome A. Montagnani, A. Rustici, M.
Andrea Montagnani, Dario Manfellotto
doaj   +1 more source

Association between triglyceride-glucose related indices and all-cause and cardiovascular mortality among the population with cardiovascular-kidney-metabolic syndrome stage 0–3: a cohort study

open access: yesCardiovascular Diabetology
Background Cardiovascular-Kidney-Metabolic (CKM) syndrome typically commences with the interaction of insulin resistance (IR), excessive or dysfunctional obesity, and the consequent systemic inflammatory response and oxidative stress.
Peng Zhang   +3 more
semanticscholar   +1 more source

Combination of Cardiovascular, Kidney, and Metabolic Diseases in a Syndrome Named Cardiovascular-Kidney-Metabolic, With New Risk Prediction Equations

open access: yesKidney International Reports
Associations of chronic kidney disease (CKD) with metabolic syndrome and cardiovascular disease (CVD) have long been recognized. Until recently, such associations were mainly limited to interrelationships between either heart and kidney, heart and ...
Ziad A. Massy, Tilman B. Drueke
doaj   +1 more source

Oxidative Stress and Inflammation as Targets for Novel Preventive and Therapeutic Approaches in Non-Communicable Diseases II

open access: yesAntioxidants, 2022
Non-communicable diseases (NCDs) are non-infectious chronic pathologies—including obesity, metabolic syndrome, chronic kidney disease (CKD), cardiovascular (CV) diseases, cancer, and chronic respiratory diseases—which represent the main cause of death ...
Chiara Nediani, Monica Dinu
doaj   +1 more source

Protein-bound uremic toxins as therapeutic targets for cardiovascular, kidney, and metabolic disorders

open access: yesFrontiers in Endocrinology
Cardiovascular-kidney-metabolic (CKM) syndrome is a systemic clinical condition characterized by pathological and physiological interactions among metabolic abnormalities, chronic kidney disease, and cardiovascular diseases, leading to multi-organ ...
Shihan Zhang   +6 more
doaj   +1 more source

Association between atherogenic index of plasma and future risk of cardiovascular disease in individuals with cardiovascular-kidney-metabolic syndrome stages 0–3: a nationwide prospective cohort study

open access: yesCardiovascular Diabetology
As an emerging concept, Cardiovascular-kidney-metabolic syndrome (CKM) elucidates the intricate interconnection between metabolic disorders(Mets), cardiovascular disease(CVD), and chronic kidney disease(CKD).
Gaoshu Zheng   +8 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy